Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
Gore
M E
ME
Biological Therapies Group, Royal Marsden Hospital, London, UK.
Riches
P
P
MacLennan
K
K
O'Brien
M
M
Moore
J
J
Dadian
G
G
Lorentzos
A
A
Garth
R
R
Moskovic
E
E
Archer
D
D
D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity*
D007376:Interleukin-2